Characterization of PARP1 in hepatocellular carcinoma, and evaluation of the potential of PARP1 inhibitor olaparib in HCC treatment
2018
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI